Natalizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Natalizumab and local guidelines before prescribing.

Anti-integrin monoclonal antibody

Mechanism

Alpha-4 integrin antagonist blocking leucocyte entry to CNS.

Uses

Relapsing multiple sclerosis, Crohn disease.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Infusion reactions, infection, liver injury, PML.

Interactions

Immunosuppressants increase PML risk.

Contraindications and cautions

PML, active infection

Monitoring

JC virus index, MRI, LFT

Pregnancy and breastfeeding

Limited data

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

JC virus antibody testing and MRI surveillance for PML; patient alert card.

More from the textbook: uses, cautions and other points
Where it is discussed in the book